Study on Sleep Quality in Cancer Survivors Diagnosed Between Ages 15 and 24

What this Trial Is About

Researchers are evaluating sleep quality in individuals who were treated for cancer during adolescence and young adulthood, between the ages of 15 and 24. This study focuses on the long-term effects of cancer treatments like chemotherapy and radiotherapy on sleep, fatigue, and related complications that may arise years after treatment. Sleep disorders are common among adolescents, and survivors often report ongoing fatigue, but the impact of cancer treatment on sleep quality in this group has not been well studied. The study involves an online survey to assess sleep quality and related factors such as anxiety, depression, and pain. Participants will complete self-administered questionnaires through the Reseau Morphee platform, which also includes a precarity scale. The study aims to identify how many participants experience moderate to severe insomnia and to explore risk factors associated with sleep disorders. Participants will provide information through this online survey, which will be used to evaluate their sleep difficulties and associated symptoms. Researchers will measure the number of patients with significant insomnia as the primary outcome and identify risk factors for sleep disorders as secondary outcomes. The study is open to patients who have completed intensive cancer treatment at least three months prior, are able to understand French, and meet other health and functional criteria. The total duration of involvement centers on completing the survey and assessments at the initial time point.

Assessment of Sleep Quality in Patients Treated for Cancer Between 15 and 24 Years of Age